Fortis Advisors, LLC Viatris Inc Transaction History

Fortis Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$10.05 - $12.02 $10 - $12	1 Added 0.01%	9,737 $103,000
Q3 2023 Nov 13, 2023	BUY	$9.59 - $11.35 $9 - $11	1 Added 0.01%	9,736 $95,000
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $84,653 - $112,224	9,708 Added 35955.56%	9,735 $108,000
Q3 2022 Nov 10, 2022	SELL	$8.48 - $11.13 $8,471 - $11,118	-999 Reduced 97.37%	27 $0
Q2 2022 Aug 15, 2022	SELL	$9.95 - $12.27 $122,076 - $150,540	-12,269 Reduced 92.28%	1,026 $11,000
Q1 2022 May 16, 2022	BUY	$9.81 - $15.4 $130,168 - $204,342	13,269 Added 51034.62%	13,295 $145,000
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $12 - $14	1 Added 4.0%	26 $0
Q4 2020 Feb 11, 2021	BUY	$14.3 - $18.74 $357 - $468	25 New	25 $0

1,136

953M

4.15M

2.65M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $10.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Fortis Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fortis Advisors, LLC with notifications on news.